首页> 外国专利> RECEPTOR-MEDIATED GENE TRANSFER SYSTEM FOR TARGETING TUMOR GENE THERAPY

RECEPTOR-MEDIATED GENE TRANSFER SYSTEM FOR TARGETING TUMOR GENE THERAPY

机译:靶向肿瘤基因的受体介导基因转移系统

摘要

The invention relates to a gene transfer system binding to a growth factorreceptor,comprising 4-element complex gene transfer system consisting of ligandoligopeptide (LOP)/polycationic polypeptide/endosome release oligopeptide/exogenous DNA or 3-element complexconsisting of ligand oligopeptide (LOP)/polycationic polypeptide/exogenousDNA. LOPselected from E5, GE7, GV1 and GV2 and constructed as a composite polypeptidevector canbe used to target exogenous genes into malignant tumor cells or tumor vascularendothelial cells.They are also able to highly inhibit the growth of tumor cells in animals whenp15, p16 orp21 WAF-1 is used as the exogenous genes. The invention also allows targetingtwo or more typesof exogenous genes and transducing exogenous genes to hemopietic, lymphoid,liver, kidney,nerve cells using a specific LOP that can recognize relevant receptorsexpressed in these cells forgene therapy.
机译:本发明涉及与生长因子结合的基因转移系统受体包含由配体组成的4元素复合基因转移系统寡肽(LOP)/多阳离子多肽/内体释放寡肽/外源DNA或3-元素复合体由配体寡肽(LOP)/聚阳离子多肽/外源性组成脱氧核糖核酸。 LOP选自E5,GE7,GV1和GV2并构建为复合多肽矢量可以用于将外源基因靶向恶性肿瘤细胞或肿瘤血管内皮细胞。它们还能够高度抑制动物体内肿瘤细胞的生长。p15,p16或p21 WAF-1被用作外源基因。本发明还允许瞄准两种以上外源基因和将外源基因转导到造血,淋巴,肝,肾,神经细胞使用可以识别相关受体的特定LOP在这些细胞中表达基因治疗。

著录项

  • 公开/公告号CA2241923C

    专利类型

  • 公开/公告日2003-12-30

    原文格式PDF

  • 申请/专利权人 SHANGHAI CANCER INSTITUTE;

    申请/专利号CA19972241923

  • 发明设计人 GU JIANREN;TIAN PEIKUN;

    申请日1997-10-27

  • 分类号C12N15/85;A61K48/00;A61K47/48;A61K31/70;C12N15/87;

  • 国家 CA

  • 入库时间 2022-08-21 23:05:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号